Dissolution behaviour of nalidixic acid solid dispersions using water soluble dispersion carriers

Acta Poloniae Pharmaceutica - Drug Research

Volumn 61, Issue 1, 2004, Pages 21-30

  Mallick, Subrata ^a   Sahu, Ashok ^a   Pal, Kaushik ^a  

^a SEEMANTA INSTITUTE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Characterization techniques; Mechanism of drug release; Nallidixic acid; Solid dispersions

Indexed keywords

BETA CYCLODEXTRIN; DRUG CARRIER; NALIDIXIC ACID; POVIDONE; STARCH GLYCOLATE SODIUM;

ANALYTIC METHOD; AQUEOUS SOLUTION; ARTICLE; CHEMICAL MODEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISPERSION; DISSOLUTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG MIXTURE; DRUG RELEASE; DRUG SOLUBILITY; EVAPORATION; INFRARED SPECTROSCOPY; PARTICLE SIZE; PHYSICAL CHEMISTRY; POWDER DIFFRACTION; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; X RAY DIFFRACTION;

DRUG CARRIERS; EXCIPIENTS; KINETICS; MICROSCOPY, ELECTRON, SCANNING; NALIDIXIC ACID; SOLUBILITY; SPECTROPHOTOMETRY, INFRARED; X-RAY DIFFRACTION;

EID: 1842450453     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Mishra L.: Drug Today. p-245, Loren Publications (India) Inc., Delhi 2001.
2. Hirasawa N., Danjo K., Haruna M., Otsuka A.: Chem. Pharm. Bull. 46, 1027 (1998).
3. Sekiguchi K., Obi N.: Chem. Pharm. Bull. 9, 866 (1961).
4. Becirevic-Lacan M., Filipovic-Grcic J., Skalko N., Jalsenjak J.: Drug Dev. Ind. Pharm. 22, 1231 (1996).
5. Chiou W.L., Riegelman S.: J. Pharm. Sci. 60, 1281 (1971).
6. Uekama K., Hirayama F., Irie T.: Chem. Rev. 98, 2045 (1998).
7. Loftsson T., Magnusdottir A., Masson M., Sigurjonsdottir J.F.: J. Pharm. Sci. 91, 2307 (2002).
8. Stella V.J., Rajewski R.A.: J. Pharm. Sci. 14, 556 (1997).
9. Suzuki H., Sunada H.: Chem. Pharm. Bull. 45, 1688 (1997).
10. Yano K., Kajiyama A., Yamazaki S., Matsumura Y., Watanabe K., Yamamoto K.: Chem. Pharm. Bull. 44, 2309 (1996).
11. Kai T., Akiyama Y., Nomura S., Sato M.: Chem. Pharm. Bull. 44, 568 (1996).
12. Taylor L.S., Zografi G.: Pharm. Res. 14, 1691 (1997).
13. Tantishaiyakul V., Kaewnoppart N., Ingkataworrwong S.: Int. J. Pharm. 143, 59 (19960.
14. Yoshioka M., Hancock B.C., Zografi G.: J. Pharm. Sci. 84, 983 (1995).
15. Stella V.J., Rao V.M., Zannou E.A., Zia V.: Adv. Drug Dev. Rev. 36, 3 (1999).
16. Cannors K.A.: J. Pharm. Sci. 84, 843 (1995).
17. Cwiertnia B., Hladon T., Stobiecki M.: J. Pharm. Pharmacol. 51, 1213 (1999).
18. Nagarsenker M.S., Meshram R.N., Ramprakash G.: J. Pharm. Pharmacol. 52, 949 (2000).
19. Khan K.A., Rhodes C.T.: Pharm. Acta Helv. 47, 5941 (1972).
20. Khan K.A.: J. Pharm. Pharmacol. 27, 48 (1975).